Search research articles
Contact Us
Filters
Showing results (691-700 of 830) with videos related to
Page
of 83
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 3, 2016
Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation
Gian D Pal, Bichun Ouyang, Geidy Serrano, et al.
Acta Neuropathologica
|
July 16, 2008
Evaluation of alpha-synuclein immunohistochemical methods used by invited experts
Thomas G Beach, Charles L White, Ronald L Hamilton, et al.
Neurology
|
May 16, 2002
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics
K Kompoliti, C H Adler, R Raman, et al.
Dementia and Geriatric Cognitive Disorders
|
September 14, 2007
Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease
M N Sabbagh, T Lahti, D J Connor, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
May 22, 2019
Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study
Bruce S Spinowitz, Steven Fishbane, Pablo E Pergola, et al.
Annals of Clinical and Translational Neurology
|
March 27, 2023
Central and peripheral α-synuclein in Parkinson disease detected by seed amplification assay
Lana M Chahine, Thomas G Beach, Charles H Adler, et al.
Journal of Neuropathology and Experimental Neurology
|
June 25, 2022
Olfactory Bulb Amyloid-β Correlates With Brain Thal Amyloid Phase and Severity of Cognitive Impairment
Cécilia Tremblay, Geidy E Serrano, Anthony J Intorcia, et al.
Neurology
|
October 27, 1997
Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients
R J Uitti, R E Wharen, M F Turk, et al.
Parkinsonism & Related Disorders
|
May 22, 2019
Regional neuropathology distribution and verbal fluency impairments in Parkinson's disease
Rasheda El-Nazer, Charles H Adler, Thomas G Beach, et al.
CNS Spectrums
|
December 28, 2018
Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus
Kevin J Black, Henry Nasrallah, Stuart Isaacson, et al.
Page
of 83
Search research articles
Search
Showing results (691-700 of 830) with videos related to
Sort By:
Page
of 83
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 3, 2016
Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation
Gian D Pal, Bichun Ouyang, Geidy Serrano, et al.
Acta Neuropathologica
|
July 16, 2008
Evaluation of alpha-synuclein immunohistochemical methods used by invited experts
Thomas G Beach, Charles L White, Ronald L Hamilton, et al.
Neurology
|
May 16, 2002
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics
K Kompoliti, C H Adler, R Raman, et al.
Dementia and Geriatric Cognitive Disorders
|
September 14, 2007
Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease
M N Sabbagh, T Lahti, D J Connor, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
May 22, 2019
Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study
Bruce S Spinowitz, Steven Fishbane, Pablo E Pergola, et al.
Annals of Clinical and Translational Neurology
|
March 27, 2023
Central and peripheral α-synuclein in Parkinson disease detected by seed amplification assay
Lana M Chahine, Thomas G Beach, Charles H Adler, et al.
Journal of Neuropathology and Experimental Neurology
|
June 25, 2022
Olfactory Bulb Amyloid-β Correlates With Brain Thal Amyloid Phase and Severity of Cognitive Impairment
Cécilia Tremblay, Geidy E Serrano, Anthony J Intorcia, et al.
Neurology
|
October 27, 1997
Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients
R J Uitti, R E Wharen, M F Turk, et al.
Parkinsonism & Related Disorders
|
May 22, 2019
Regional neuropathology distribution and verbal fluency impairments in Parkinson's disease
Rasheda El-Nazer, Charles H Adler, Thomas G Beach, et al.
CNS Spectrums
|
December 28, 2018
Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus
Kevin J Black, Henry Nasrallah, Stuart Isaacson, et al.
Page
of 83